Literature DB >> 15101810

Speech-language pathologists' roles in the delivery of positive behavior support for individuals with developmental disabilities.

Karen D Bopp1, Kenneth E Brown, Pat Mirenda.   

Abstract

Positive behavior support interventions such as functional communication training (FCT) and visual schedules are increasingly being used with individuals with autism and other severe developmental disabilities who engage in problem behavior and use augmentative and alternative communication (AAC). The increasing use of these communication interventions has implications for speech-language pathologists who provide support to these individuals. The purpose of this tutorial is to summarize the research regarding the use of FCT/AAC interventions and visual schedules, and to provide suggestions for the roles that speech-language pathologists can play with regard to assessment, intervention design, and implementation in school and home settings.

Entities:  

Mesh:

Year:  2004        PMID: 15101810     DOI: 10.1044/1058-0360(2004/003)

Source DB:  PubMed          Journal:  Am J Speech Lang Pathol        ISSN: 1058-0360            Impact factor:   2.408


  3 in total

1.  Preliminary investigation of visual attention to human figures in photographs: potential considerations for the design of aided AAC visual scene displays.

Authors:  Krista M Wilkinson; Janice Light
Journal:  J Speech Lang Hear Res       Date:  2011-08-23       Impact factor: 2.297

Review 2.  Considerations for the composition of visual scene displays: potential contributions of information from visual and cognitive sciences.

Authors:  Krista M Wilkinson; Janice Light; Kathryn Drager
Journal:  Augment Altern Commun       Date:  2012-09       Impact factor: 2.214

Review 3.  The behavioral phenotype of Rubinstein-Taybi syndrome: A scoping review of the literature.

Authors:  Neelam Awan; Effie Pearson; Lauren Shelley; Courtney Greenhill; Joanne Tarver; Jane Waite
Journal:  Am J Med Genet A       Date:  2022-06-21       Impact factor: 2.578

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.